Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  EGFR inhibitor ASP8273
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 8273-CL-0302, NCI-2016-00113, 2015-002894-39, NCT02588261
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 8273-CL-0201, NCI-2017-00664, 2016-003183-39, NCT03042013
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 8273-CL-0112, NCI-2017-00665, NCT03082300
Start Over